Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Playing Defense Against Lou Gehrig's Disease
 
research article

Playing Defense Against Lou Gehrig's Disease

Aebischer, Patrick  
•
Kato, Ann C.
2007
Scientific American

The official name of the illness is amyotrophic lateral sclerosis (ALS), but in the U.S. it is better known as Lou Gehrig’s disease. The great New York Yankees first baseman was diagnosed with ALS in 1939 and died two years later from the progressive neuromuscular disorder, which attacks nerve cells that lead from the brain and the spinal cord to muscles throughout the body. When these motor neurons die, the brain can no longer control muscle movements; in the later stages of the disease, patients become totally paralyzed. First described in 1869 by French clinician Jean-Martin Charcot, ALS is a misunderstood illness. Doctors once thought it was rare but now consider it fairly common: about 5,000 people in the U.S. are diagnosed with ALS every year. In total there are about 30,000 ALS patients in the U.S. and approximately 5,000 in the U.K. ALS typically develops between the ages of 40 and 70, but the disease strikes younger and older patients as well. Other well-known people who suffered from ALS include British actor David Niven, Russian composer Dmitri Shostakovich and Chinese leader Mao Tse-tung. Researchers have found unusual clusters of patients with the disorder among Italian soccer players, veterans of the Persian Gulf War and residents of the island of Guam, although no one knows why.

  • Files
  • Details
  • Metrics
Type
research article
DOI
10.1038/scientificamerican1107-86
Web of Science ID

WOS:000250272100033

Author(s)
Aebischer, Patrick  
Kato, Ann C.
Date Issued

2007

Published in
Scientific American
Volume

297

Issue

5

Start page

86

End page

93

Note

Researchers have proposed potential therapies for a paralyzing disorder once thought to be untreatable. For copyright reasons, the figures, drawings and pictures of the publicly available full text have been removed. The full and complete paper is available on the web site of the publisher for subscribers : http://www.sciam.com

URL

URL

http://www.sciam.com
Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LEN  
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/15228
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés